We are live on ! Find out more
PCM

Portolan Capital Management Portfolio holdings

AUM $2.67B
1-Year Est. Return 169.09%
This Fund
S&P 500
This Quarter Est. Return
+3.72%
1 Year Est. Return
+169.09%
3 Year Est. Return
+737.83%
5 Year Est. Return
+1,497.12%
10 Year Est. Return
+21,256.61%
AUM
$1.21B
AUM Growth
-$98.5M
Cap. Flow
-$79M
Cap. Flow %
-6.5%
Top 10 Hldgs %
27.39%
Holding
137
New
21
Increased
36
Reduced
59
Closed
20

Top Buys

Rank Stock Value
1
QTRX icon
Quanterix
QTRX
+$12.6M
2
PHAT icon
Phathom Pharmaceuticals
PHAT
+$11.6M
3
TTMI icon
TTM Technologies
TTMI
+$11.5M
4
ORN icon
Orion Group Holdings
ORN
+$11.2M
5
MRVI icon
Maravai LifeSciences
MRVI
+$10.1M

Top Sells

Rank Stock Value
1
BIO icon
Bio-Rad Laboratories Class A
BIO
+$19.2M
2
WKME
WalkMe Ltd. Ordinary Shares
WKME
+$19.1M
3
SG icon
Sweetgreen
SG
+$15.8M
4
UTHR icon
United Therapeutics
UTHR
+$14.8M
5
RCM
R1 RCM Inc. Common Stock
RCM
+$14.1M

Sector Composition

Rank Sector Weight
1 Technology 33.79%
2 Healthcare 21.3%
3 Industrials 12.49%
4 Consumer Discretionary 8.15%
5 Communication Services 6.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BASE
51
DELISTED
Couchbase
BASE
$8.98M 0.74%
491,944
-98,510
-17% -$2.29M
VRT icon
52
Vertiv
VRT
$112B
$8.87M 0.73%
102,466
-27,457
-21% -$2.5M
GTES icon
53
Gates Industrial Corp
GTES
$6.49B
$8.83M 0.73%
558,192
+341,160
+157% +$5.78M
AU icon
54
AngloGold Ashanti
AU
$54.5B
$8.33M 0.69%
331,286
-207,371
-38% -$4.92M
MITK icon
55
Mitek Systems
MITK
$805M
$8.3M 0.68%
+742,728
New +$9.51M
TECK icon
56
Teck Resources
TECK
$35.3B
$7.61M 0.63%
+158,961
New +$7.82M
ENVA icon
57
Enova International
ENVA
$5.62B
$7.6M 0.63%
122,081
-1,432
-1% -$87.4K
RPAY icon
58
Repay Holdings
RPAY
$305M
$7.55M 0.62%
715,111
-100,396
-12% -$1.03M
BIDU icon
59
Baidu
BIDU
$31.6B
$7.34M 0.6%
84,847
-107,575
-56% -$10.8M
STNG icon
60
Scorpio Tankers
STNG
$4.11B
$7.32M 0.6%
90,006
-29,027
-24% -$2.22M
LUXE
61
LuxExperience B.V.
LUXE
$1.01B
$7.05M 0.58%
1,382,816
+670,821
+94% +$3.08M
EGO icon
62
Eldorado Gold
EGO
$11.4B
$6.98M 0.58%
472,142
-103,315
-18% -$1.57M
AAOI icon
63
Applied Optoelectronics
AAOI
$9.47B
$6.97M 0.57%
841,059
-593,841
-41% -$6.53M
BIO icon
64
Bio-Rad Laboratories Class A
BIO
$10.2B
$6.87M 0.57%
25,150
-65,842
-72% -$19.2M
SLM icon
65
SLM Corp
SLM
$4.94B
$6.63M 0.55%
318,697
+278,278
+688% +$5.86M
MXCT icon
66
MaxCyte
MXCT
$132M
$6.62M 0.54%
1,687,650
-34,127
-2% -$147K
MDU icon
67
MDU Resources
MDU
$4.17B
$6.58M 0.54%
+472,935
New +$6.53M
INFN
68
DELISTED
Infinera Corporation Common Stock
INFN
$6.56M 0.54%
+1,077,664
New +$5.7M
BV icon
69
BrightView Holdings
BV
$1.04B
$6.45M 0.53%
485,165
-235,215
-33% -$3M
TTWO icon
70
Take-Two Interactive
TTWO
$39.9B
$6.43M 0.53%
41,384
-27,733
-40% -$4.21M
STKL
71
DELISTED
SunOpta
STKL
$6.39M 0.53%
1,183,964
-1,083,209
-48% -$6.36M
PRIM icon
72
Primoris Services
PRIM
$4.06B
$6.31M 0.52%
+126,542
New +$6.26M
VRN
73
DELISTED
Veren
VRN
$6.23M 0.51%
791,988
+15,128
+2% +$127K
OPRA
74
Opera Ltd
OPRA
$1.63B
$6.11M 0.5%
+435,464
New +$6.19M
RDNT icon
75
RadNet
RDNT
$5.66B
$5.97M 0.49%
101,347
+7,366
+8% +$400K
1 2
3
4 5

Similar funds

IAS
Insigneo Advisory Services Miami, Florida $2.67B AUM 40.6% 1-Year Est. Return
ORIO
Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return
BWFA
Baltimore-Washington Financial Advisors Columbia, Maryland $2.67B AUM 19.65% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $2.68B AUM 34.39% 1-Year Est. Return
MMC
Mizuho Markets Cayman Grand Cayman, Cayman Islands $2.67B AUM 103.47% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.68B AUM
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return
UPS
UHLMANN PRICE SECURITIES Skokie, Illinois $2.68B AUM 149.5% 1-Year Est. Return

Portolan Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Portolan Capital Management held 137 positions worth $1.21B, down 7.5% from $1.31B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Portolan Capital Management withdrew a net $79M in Q2 2024, closing 20 positions and reducing 59 holdings. Its most notable exit was R1 RCM Inc. Common Stock, an estimated $14.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 35% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Portolan Capital Management opened a new position in Phathom Pharmaceuticals worth $11.6M.

  • Portolan Capital Management's largest Q2 2024 buy was Phathom Pharmaceuticals: 1,130,089 shares worth $11.6M.
  • Portolan Capital Management added most to Quanterix in Q2 2024, an estimated $12.6M increase.
  • Portolan Capital Management's biggest Q2 2024 reduction was Bio-Rad Laboratories Class A, cutting an estimated $19.2M.
  • Portolan Capital Management fully exited R1 RCM Inc. Common Stock in Q2 2024, selling an estimated $14.1M.
  • Portolan Capital Management's ten largest holdings make up 27% of its $1.21B portfolio in Q2 2024.
  • Portolan Capital Management opened 21 new positions and closed 20 in Q2 2024.
  • Portolan Capital Management's portfolio value fell 7.5% quarter-over-quarter to $1.21B.

Based on Portolan Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.